Prenetics News and Activities

Prenetics is a company listed under the stock ticker PRE (HK).

Acquisition, funding and merger involving Prenetics.

• Prenetics has just announced a $20 Million fundraising (posted on June 19 2025).

View the org chart displaying its 20 main executives

Most searched biographies at Prenetics

• Danny Yeung, Chief Executive Officer and Insighta
• Hudson Leogrande, Director
• Ben Cheng, Director

Popular executive movements at Prenetics

• Hudson Leogrande has joined the company as Chief Executive Officer, Comfrt  (posted on June 5 2026).
• Brian Rosin has joined the company as Chief Financial Officer  (posted on May 14 2026).
• Stephen Lo, Chief Financial Officer, has left the company  (posted on May 14 2026).

Click here to view some more movements at Prenetics

Create your alert
to follow the executive moves at Prenetics.

Prenetics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Prenetics

Social media about Prenetics

• Prenetics on Wikipedia, Google News & Yahoo Finance
• Prenetics on LinkedIn, X (Twitter) & YouTube